1 | ACR-16 | Acr16 5件: Acr16; Acr16 10 mg; Acr16 22.5 mg; Acr16 45 mg; Acr16 hydrochloride, asp2314 hydrochloride, fr310826; | - |
- |
- |
008 1件: 8 💬 |
2 | Alprazolam | Alprazolam 1件: Alprazolam; | 1件: D00225 D00225 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
008 1件: 8 💬 |
3 | Amantadine | 240mg amantadine hcl er tablets 13件: 240mg amantadine hcl er tablets; 320mg amantadine hcl er tablets; Ads-5102 (extended release amantadine hcl); Amantadine; Amantadine 300 mg; Amantadine hcl er; Amantadine hcl extended release; Amantadine hcl extended release capsule; Amantadine hydrochloride; Amantadine hydrochloride (hcl); Amantadine sulfate; Determination of drug effects through amantadine cessation; Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj; | 2件: D00777 D00777
D07441 D07441 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 4件: 6 , 8 , 13, 127 💬 |
4 | Atomoxetine | Atomoxetine 1件: Atomoxetine; | 2件: D02574 D02574
D07473 D07473 💬 |
1件: SLC6A2 💬 |
Synaptic vesicle cycle 1件: Synaptic vesicle cycle |
006 3件: 6 , 8 , 13 💬 |
5 | Bevantolol | Bevantolol 2件: Bevantolol; Bevantolol hydrochloride; | - |
- |
- |
008 1件: 8 💬 |
6 | Biotin | Biotin 7件: Biotin; Biotina; D-biotin; D-biotina; High doses of thiamine y biotin; Moderate doses of thiamine y biotin; Prebiotics (prebiotin prebiotic fiber stick pac); | 1件: D00029 D00029 💬 |
- |
- |
002 5件: 2 , 8 , 10, 13, 20 💬 |
7 | Bupropion | Bupropion 4件: Bupropion; Bupropion & citalopram; Bupropion hydrochloride; Wellbutrin (bupropion); | 3件: D00817 D00817
D07591 D07591
D07938 D07938 💬 |
2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
008 5件: 8 , 18, 21, 96, 171 💬 |
8 | Cannabidiol | Avcn583601 (3% cannabidiol cream) 11件: Avcn583601 (3% cannabidiol cream); Cannabidiol; Cannabidiol (cbd); Cannabidiol , synthetic form; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol botanical drug substance (cbd bds); Cannabidiol capsule 5 mg; Cannabidiol oral solution; Cannabidiol tablet 10 mg; Cannabidiol vaginal suppository; Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd); | 1件: D10915 D10915 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 19件: 2 , 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
9 | Citalopram | 20mg daily citalopram 8件: 20mg daily citalopram; Bupropion & citalopram; Citalopram; Citalopram 20mg; Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; | 2件: D00822 D00822
D07704 D07704 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6 , 8 , 13, 18, 46, 127 💬 |
10 | Creatine | Creatine 4件: Creatine; Creatine monohydrate; Creatine-13c; Pyruvate, creatine, niacinamide; | - |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
11 | Cysteamine | Cystagon (cysteamine bitartrate) immediate-release capsules 13件: Cystagon (cysteamine bitartrate) immediate-release capsules; Cystagon® (cysteamine bitartrate); Cysteamine; Cysteamine (mercaptamine) viscous solution; Cysteamine bitartrate; Cysteamine bitartrate (cystagon); Cysteamine bitartrate (inn: mercaptamine bitartrate; Cysteamine bitartrate (inn: mercaptamine bitartrate ); Cysteamine bitartrate (inn: mercaptamine bitartrate); Cysteamine bitartrate delayed-release capsules; Cysteamine bitartrate delayed-release capsules (rp103); Cysteamine hydrochloride; Other: cysteamine bitartrate; | 2件: D03634 D03634
D03635 D03635 💬 |
- |
- |
008 4件: 8 , 19, 21, 299 💬 |
12 | Deutetrabenazine | Deutetrabenazine 2件: Deutetrabenazine; Deutetrabenazine oral tablet [austedo]; | 1件: D10701 D10701 💬 |
1件: SLC18A2 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
13 | Dextromethorphan | Dextromethorphan 10件: Dextromethorphan; Dextromethorphan 30 mg; Dextromethorphan and caffeine; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; | 3件: D00848 D00848
D03742 D03742
D03744 D03744 💬 |
6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
14 | Digoxin | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 3件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Digoxin; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; | 1件: D00298 D00298 💬 |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 |
Adrenergic signaling in cardiomyocytes 18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
008 3件: 8 , 46, 210 💬 |
15 | Dronabinol | Cannabidiol / dronabinol capsule 5 mg+2,5 mg 5件: Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Dronabinol; Dronabinol 25 mg/ml, oral drops; Dronabinol capsule 2,5 mg; Dronabinol capsule 2.5. mg; | 1件: D00306 D00306 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 7件: 2 , 8 , 13, 46, 96, 271, 298 💬 |
16 | Epigallocatechin | (2)-epigallocatechin-3-gallate (egcg) 7件: (2)-epigallocatechin-3-gallate (egcg); Coconut oil and epigallocatechin gallate; Epigallocatechin; Epigallocatechin gallate; Epigallocatechin-3-gallate (egcg); Epigallocatechin-gallate; Epigallocatechin-gallate (sunphenon); | - |
- |
- |
008 5件: 8 , 13, 28, 85, 113 💬 |
17 | Epigallocatechin gallate | Coconut oil and epigallocatechin gallate 2件: Coconut oil and epigallocatechin gallate; Epigallocatechin gallate; | - |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
18 | Fenofibrate | Fenofibrate 2件: Fenofibrate; Fenofibrate idd-p (insoluble drug delivery-micro particle); | 1件: D00565 D00565 💬 |
1件: PPARA 💬 |
Adipocytokine signaling pathway 8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
008 5件: 8 , 79, 93, 94, 265 💬 |
19 | GSK-356278 | Gsk356278 1件: Gsk356278; | - |
- |
- |
008 1件: 8 💬 |
20 | Haloperidol | Haloperidol 1件: Haloperidol; | 2件: D00136 D00136
D01898 D01898 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 1件: 8 💬 |
21 | Icosapent | Eicosapentaenoic acid 4件: Eicosapentaenoic acid; Ethyl icosapent; Ethyl-icosapent; Icosapent; | 1件: D08061 D08061 💬 |
- |
- |
008 10件: 8 , 46, 48, 49, 96, 97, 113, 296, 297, 301 💬 |
22 | Icosapent ethyl | - | 1件: D01892 D01892 💬 |
- |
- |
008 2件: 8 , 296 💬 |
23 | Ketoconazole | 2s,4r-(-)-ketoconazole 5件: 2s,4r-(-)-ketoconazole; 2s,4r-(-)-ketoconazole, levoketoconazole; Dimebon + ketoconazole; Ketoconazole; Levoketoconazole; | 1件: D00351 D00351 💬 |
1件: CYP17A1 💬 |
Cortisol synthesis and secretion 6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
008 3件: 8 , 13, 75 💬 |
24 | Laquinimod | Cápsulas de laquinimod 0.6 mg 12件: Cápsulas de laquinimod 0.6 mg; Laquinimod; Laquinimod 0.3; Laquinimod 0.6; Laquinimod 1.2; Laquinimod capsulas 0.6 mg; Laquinimod capsules 0.3 mg; Laquinimod capsules 0.5 mg; Laquinimod capsules 0.6 mg; Laquinimod cápsulas 0.5 mg; Laquinimod sodium (usan); Laquinimod tablets 0.3 mg; | - |
- |
- |
008 4件: 8 , 13, 49, 96 💬 |
25 | Latrepirdine | Dimebon (latrepirdine) 2件: Dimebon (latrepirdine); Latrepirdine; | 1件: D09917 D09917 💬 |
6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
26 | LAX-101 | Lax-101 1件: Lax-101; | - |
- |
- |
008 1件: 8 💬 |
27 | Lithium citrate | Lithium citrate 1件: Lithium citrate; | 1件: D04749 D04749 💬 |
- |
- |
002 5件: 2 , 5 , 6 , 7 , 8 💬 |
28 | Melatonin | 3 mg melatonin 11件: 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin; Melatonin cr; Melatonin pr; Melatonin(circadin®); Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.; | 1件: D08170 D08170 💬 |
2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
29 | Memantine | Memantine 5件: Memantine; Memantine (drug); Memantine (ebixa); Memantine hydrochloride; Memantine hydrochloride oral solution; | 2件: D04905 D04905
D08174 D08174 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 7件: 2 , 6 , 8 , 13, 49, 127, 205 💬 |
30 | Minocycline | Combination of minocycline and mtx or mtx alone 8件: Combination of minocycline and mtx or mtx alone; Glatiramer acetate with minocycline; Lovastatin, then minocycline/lovastatin; Minocycline; Minocycline 100 mg film-coated tablets; Minocycline 100mg; Minocycline hydrochloride; Minocycline, then minocycline/lovastatin; | 2件: D00850 D00850
D05045 D05045 💬 |
- |
- |
002 14件: 2 , 6 , 8 , 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
31 | Neflamapimod | Neflamapimod 1件: Neflamapimod; | 1件: D10959 D10959 💬 |
4件: MAPK11, MAPK12, MAPK13, MAPK14 💬 |
AGE-RAGE signaling pathway in diabetic complications 58件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection |
008 1件: 8 💬 |
32 | Nilotinib | Cohort 1:nilotinib oral capsules (150mg or 300mg) 9件: Cohort 1:nilotinib oral capsules (150mg or 300mg); Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1); Nilotinib; Nilotinib (tasigna); Nilotinib 150 mg; Nilotinib 150mg oral capsule [tasigna]; Nilotinib 300mg oral capsule [tasigna]; Nilotinib 50 mg; Nilotinib hydrochloride monohydrate; | 1件: D08953 D08953 💬 |
4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 5件: 6 , 8 , 34, 51, 86 💬 |
33 | Olanzapine | Olanzapine 1件: Olanzapine; | 2件: D00454 D00454
D06623 D06623 💬 |
11件: ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 |
AMPK signaling pathway 16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 2件: 2 , 8 💬 |
34 | Omeprazole | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 19件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Clartihromycin, amoxicillin, and omeprazole; Diclofenac + omeprazole; Dimebon + omeprazole; Esomeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Nexium (esomeprazole magnesium); Omeprazole; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 20mg; Omeprazole 20mg bid; Omeprazole 40 mg; Omeprazole 40mg capsule; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Rifaximin+omeprazole+miralax; | 4件: D00455 D00455
D01207 D01207
D05259 D05259
D05261 D05261 💬 |
2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
35 | Phenylbutyric acid | - | 1件: D05868 D05868 💬 |
- |
- |
002 12件: 2 , 3 , 6 , 8 , 15, 93, 94, 231, 244, 251, 297, 299 💬 |
36 | Phosphorus | Other: 31-phosphorus rmn spectroscopy 2件: Other: 31-phosphorus rmn spectroscopy; Phosphorus; | - |
- |
- |
008 2件: 8 , 58 💬 |
37 | Pridopidine | Pridopidine 3件: Pridopidine; Pridopidine (90 mg); Pridopidine hydrochloride; | 1件: D09953 D09953 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 3件: 2 , 6 , 8 💬 |
38 | Quinidine | Dextromethorphan hbr and quinidine sulfate 7件: Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Quinidine; Quinidine sulfate; | 4件: D00642 D00642
D00643 D00643
D02272 D02272
D08458 D08458 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 3件: 2 , 8 , 13 💬 |
39 | Ramelteon | Ramelteon 1件: Ramelteon; | 1件: D02689 D02689 💬 |
2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 3件: 6 , 8 , 46 💬 |
40 | Resveratrol | Liposomed polyphenols resveratrol and curcumin 2件: Liposomed polyphenols resveratrol and curcumin; Resveratrol; | - |
- |
- |
002 6件: 2 , 8 , 18, 89, 113, 299 💬 |
41 | Rilmenidine | Rilmenidine 1件: Rilmenidine; | 1件: D08482 D08482 💬 |
3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
008 1件: 8 💬 |
42 | Riluzole | Plasma from healthy young people treatment + riluzole 8件: Plasma from healthy young people treatment + riluzole; Riluzole; Riluzole (100 mg); Riluzole 50 mg; Riluzole 50 mg (part b); Riluzole oral soluble film; Riluzole oral soluble film (rosf) 50 mg; Riluzole pmcs; | 1件: D00775 D00775 💬 |
14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
43 | Risperidone | Methylphenidate, fluoxetin, risperidone 2件: Methylphenidate, fluoxetin, risperidone; Risperidone; | 1件: D00426 D00426 💬 |
2件: DRD2, HTR2A 💬 |
Alcoholism 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
008 5件: 8 , 156, 179, 187, 206 💬 |
44 | Rolipram | Rolipram 1件: Rolipram; | 1件: D01783 D01783 💬 |
4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
008 2件: 8 , 13 💬 |
45 | Selisistat | Selisistat 1件: Selisistat; | - |
- |
- |
008 1件: 8 💬 |
46 | Tetrabenazine | Deutetrabenazine 4件: Deutetrabenazine; Deutetrabenazine oral tablet [austedo]; Tetrabenazine; Tetrabenazine withdrawal; | 1件: D08575 D08575 💬 |
1件: SLC18A2 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
47 | Thiamine | Cofactor supplementation (thiamine, riboflavin, l-carnitine) 4件: Cofactor supplementation (thiamine, riboflavin, l-carnitine); High doses of thiamine y biotin; Moderate doses of thiamine y biotin; Thiamine; | 1件: D08580 D08580 💬 |
- |
- |
008 3件: 8 , 13, 265 💬 |
48 | Tiapride | - | 1件: D08590 D08590 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 1件: 8 💬 |
49 | Triheptanoin | Triheptanoin 5件: Triheptanoin; Triheptanoin / triheptanoina; Triheptanoin 1g/kg/day; Triheptanoin oil; Triheptanoina; | 1件: D11465 D11465 💬 |
- |
- |
002 9件: 2 , 8 , 149, 156, 248, 256, 257, 317, 324 💬 |
50 | Ubidecarenone | - | 1件: D01065 D01065 💬 |
- |
- |
002 13件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 86, 113, 193, 214, 215 💬 |
51 | Ubiquinol | Ubiquinol 1件: Ubiquinol; | - |
- |
- |
006 3件: 6 , 8 , 17 💬 |
52 | Ursodeoxycholic acid | Norursodeoxycholic acid 16件: Norursodeoxycholic acid; Tauroursodeoxycholic acid; Tauroursodeoxycholic acid capsules; Tauroursoursodeoxycholic acid, brand name tudcabil; Udca (ursodeoxycholic acid); Ursodeoxycholic acid; Ursodeoxycholic acid (udca); Ursodeoxycholic acid (urso); Ursodeoxycholic acid 300mg capsule; Ursodeoxycholic acid 300mg tablet; Ursodeoxycholic acid capsules; Ursodeoxycholic acid combination of immunosuppressive agents; Ursodeoxycholic acid combined with total glucosides of paeony; Ursodeoxycholic acid only; Ursodeoxycholic acid+low dose glucocorticoid(prednisone); Ursodiol (ursodeoxycholic acid, udca); | 1件: D00734 D00734 💬 |
1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
006 13件: 6 , 8 , 20, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬 |
53 | Valbenazine | Valbenazine 1件: Valbenazine; | 1件: D10675 D10675 💬 |
1件: SLC18A2 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 1件: 8 💬 |
54 | Warfarin | S-warfarin 6件: S-warfarin; The generic name is warfarin and many producers will be involved; Warfarin; Warfarin 10 mg; Warfarin sodium; Warfarin+ vitamin k; | 3件: D00564 D00564
D01280 D01280
D08682 D08682 💬 |
2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |